AI, breast cancer

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...
AI-supported mammography screening significantly increases breast cancer detection rates while maintaining comparable recall ...
Another new year, another half-billion-biobuck transaction between Insilico Medicine and the Italian drugmaker Menarini Group ...
Done right, with real-world evidence to back up the claims and persuade doctors to adopt it, artificial intelligence has the ...
With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...
In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...